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SUMMARY
The antibody response to group A streptococcal cell wall components was measured in
rats during the development ofchronic, remittent experimental arthritis. The arthritis was
induced by a single intraperitoneal injection of an aqueous suspension of group A
streptococcal cell wall fragments and antibodies were measured by a radioactive antigen-
binding assay. Antibodies in serum against both peptidoglycan and A polysaccharide
reached maximum levels at 1 or 2 weeks and declined to preimmunization levels by day 63.
The kinetics and magnitude of the antibody responses were similar in neonatally thymec-
tomized and non-thymectomized rats. A relationship between chronic joint lesions and
anti-peptidoglycan concentration in serum was indicated, since all rats which produced
high levels ofantibody developed severe chronic arthritis. However, 46% ofthe rats which
produced very low levels of antibody also developed moderate to severe arthritis. There
was no correlation between anti-A polysaccharide antibodies and joint disease, although
the concentration of this antibody was 10- to 100-fold greater than the anti-peptidoglycan.
We conclude that antibody can be a component in the pathogenesis of this experimental
model of arthritis, but its role requires further elucidation.
INTRODUCTION
Rats given a single intraperitoneal injection ofan aqueous suspension ofgroup A streptococcal cell
wall fragments develop a chronic, remittent, erosive polyarthritis of the fore and hind limbs
(Cromartie et al., 1977; Clark et al., 1979). Joint inflammation is associated with the localization of
cell wall fragments in the synovial and periarticular tissues, and cell wall antigens can be detected
within these tissues by immunofluorescence for at least 180 days. The essential components of the
purified cell walls are the covalently bound polymers of peptidoglycan and group-specific A
polysaccharide.
The role of the immune response in this experimental arthritis is not clear. Since this disease
develops in neonatally thymectomized rats and does not correlate with delayed hypersensitivity
against peptidoglycan (Hunter et al., 1980) it does not appear to be the result of cell-mediated
immune mechanisms. The studies on the immune response have been extended by measuring the
serum antibody levels against peptidoglycan and groupA polysaccharide in rats given arthropatho-
genic doses of group A streptococcal cell wall fragments. This paper reports (i) the time-course of
the antibody response to peptidoglycan and group A polysaccharide; (ii) the effect of cell wall dose
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and neonatal thymectomy on the antibody response to cell wall antigens; and (iii) the relationship of
serum antibody concentrations to the development of experimental arthritis.
MATERIALS AND METHODS
Bacterial cells and cell walls. Detailed procedures have been described elsewhere (Hunter et al.,
1980; Cromartie et al., 1977). Group A streptococci type 3, strain D-58 were grown in Todd-Hewitt
broth (BBL Microbiology Systems, Cockeysville, Maryland) for 16 hr at 370C. Cells were collected
by centrifugation, washed three times with cold saline and disrupted in a Braun shaker. The cell
walls were isolated by differential centrifugation, treated with trypsin and ribonuclease, washed,
dialysed against distilled water and lyophilized.
Cell wallfragments. Purified group A streptococcal cell walls were suspended in phosphate-buf-
fered saline (PBS) pH 7 2 and sonicated for 70 min in a Branson Sonifier (Model S 125, Heat Systems
Co., New York) at maximum power. The disrupted cell walls were then filtered through millipore
filters (Millipore Corp., Bedford, Massachusetts) of 1-2- and 0 45-tim pore size. Preparations were
tested for sterility by plating 0 1 ml onto sheep blood agar plates. The rhamnose content of the
disrupted cell walls was measured by the method of Dische & Shettles (1948).
Cell wallpeptidoglycan andA polysaccharide. Streptococcal group-specific polysaccharides were
prepared from group A and group A-variant streptococci by extraction of purified cell walls by the
formamide extraction method of Fuller (1938) as described by Krause & McCarty (1961). The
peptidoglycan moiety was obtained by formamide extraction of group A-variant cell walls as
described by Krause & McCarty (1961).
Induction of experimental arthritis. Outbred Sprague-Dawley rats were obtained from Zivic-
Miller, Allison Park, Pennsylvania. Rats weighing approximately 100 g were used in all experi-
ments. To induce arthritis, rats were given a single intraperitoneal injection of an aqueous
suspension of sterile group A streptococcal cell wall fragments at doses of 60, 20 or 5 mig of
rhamnose/g body weight. These doses are equivalent to 20, 6 6 or 1 66 mg of cell wall material per
100-g rat.
Quantitative precipitin analysis. Quantitative precipitin analysis was performed on hyperim-
mune rat antisera to determine the amount of antibody to A polysaccharide and peptidoglycan.
These antisera were then diluted to contain known amounts of antibody and used to prepare
standard curves in the antigen-binding assay. Rats were hyperimmunized with group A streptococ-
cal vaccines as described by Greenblatt et al. (1971).
Tyrosylation and radioiodination ofpeptidoglycan andA polysaccharide. Before iodinating it was
necessary to insert phenolic groups by first treating the polysaccharide or peptidoglycan with
cyanogen bromide (Axen, Porath & Ernback, 1967) and then reacting the activated structures with
tyramine as described by Gotschlich et al. (1972). Radioiodination was performed by a modifica-
tion of the chloramine T method described by Gotschlich et al. (1972).
Antibody measurement. Antibodies specific for peptidoglycan and group A polysaccharide were
measured by a radioactive antigen-binding assay. The methods described by Heymer et al. (1975a)
for peptidoglycan, and Bernstein, Klapper & Krause (1975) for polysaccharide were adapted to rat
serum. The double-isotope method of Gotschlich (1971) using 22Na as a volume marker was used.
Labelled polysaccharide bound to antibody was precipitated with 10% polyethylene glycol 6000.
The per cent antigen bound was compared to a standard curve ofknown antibody concentrations as
determined by quantitative precipitin analysis. A computer program was developed using a
statistical analysis system (Barr et al., 1976) to perform the calculations. Results are expressed as ,g
antibody/ml of serum.
Thymectomy. Neonatal thymectomy was performed within 24 hr of birth by a combination of
blunt dissection and suction. Littermates were matched for thymectomy or sham-thymectomy and
males and females were included in both groups. After the animals had been killed a histological
evaluation of thymectomy was performed and animals with more than 10% thymus were not
included in the data.
Statistical analysis. All data was indexed on computer cards and all statistical analyses including
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Student's t-test, analysis of variance, correlation coefficients, linear regression analysis, lack-of-fit
analysis and frequency distribution were performed using an IBM 360/75 computer and Statistical
Analysis System (SAS) (Barr et al., 1976). Unless otherwise noted all statistical analyses were
performed using the logarithm of the antibody concentration.
Method ofscoring arthritis. Arthritis was scored by a method similar to that ofWood, Pearson &
Tanaka (1969) for scoring adjuvant arthritis. The severity of the arthritis was graded on a scale of
0-4 for each extremity with a maximum total possible score of 16. The scoring is based on the
number ofjoints involved, severity and extent of erythema and oedema of the periarticular tissues
and enlargement, distortion and ankylosis of the joints. The joints scored were those of each
extremity distal to the knees and elbows. Joint lesions were also assessed by X-ray and scored by a
radiographic technique (Clark et al., 1979).
RESULTS
Kinetics of the antibody response in thymectomized and non-thymectomized rats
All animals were injected intraperitoneally with group A streptococcal cell wall fragments in a dose
of 60 pg of rhamnose per g body weight. Serum was collected 3 days before injection and at 3, 7, 14,
30, 42 and 63 days after injection for measurement of antibodies against peptidoglycan and
group-specific A polysaccharide. Rats were also examined clinically and radiographically for joint
inflammation and bone changes.
The anti-A polysaccharide antibody in thymectomized and non-thymectomized rats is shown in





<1( -) . *A. Nk M- -
0o 1-0 0 81-5 874532 23-1 12 4-8 5-25 1.0± sOcm t0 !*1" * 0! 61-5 373 !3 15-7 !8'oo4-6 5 400 "4 *0
0 3 7 4 30 42 63
Days after injection
Fig. 1. Anti-A polysaccharide antibody concentration in the sera of neonatally thymectomized (o) and
non-thymectomized (-) rats injected i.p. with group A streptococcal cell wall fragments (60 pug ofrhamnose per g
body weight). Bars indicate mean. Each point represents one rat.
peak at day 7 or day 14 and declined slowly toward preimmunization levels by day 63. The response
of some individual thymectomized animals to the polysaccharide was higher than non-thymecto-
mized rats, but the differences between the mean values of the two groups were not significant at any
time interval. Though not shown here, unimmunized control rats examined over the same interval
showed no measurable anti-A polysaccharide antibodies.
Serum anti-peptidoglycan antibody concentration in thymectomized and non-thymectomized
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rats is shown in Fig. 2. Antibody was detectable in both groups 3 days after cell wall injection and
reached peak levels between 7 to 14 days. Antibody levels then declined to preimmunization levels
by day 63. Similar to the anti-A polysaccharide response, several thymectomized rats had higher
anti-peptidoglycan antibody levels than non-thymectomized rats, but the differences between
groups were not significant.
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Fig. 2. Anti-peptidoglycan antibody concentration in the sera ofneonatally thymectomized (o) and non-thymec-
tomized (c) rats injected i.p. with group A streptococcal cell wall fragments (60 pg of rhamnose per g body
weight).
Effect of cell wall dose on the antibody responses of thymectomized and non-thymectomized rats
The antibody responses to A polysaccharide and peptidoglycan were measured in thymectomized
and non-thymectomized rats injected with cell wall fragments in doses of 60, 20 or 5 pg of
rhamnose/g body weight. All groups reached peak antibody levels by 1 or 2 weeks.
The effects of dose and treatment (thymectomy and non-thymectomy), as well as interactions
between dose and treatment were examined by analysis of variance. There were no significant
quantitative differences in antibody to A polysaccharide over this range of arthritogenic doses of
cell wall. When the maximum anti-A polysaccharide of non-thymectomized and thymectomized
rats was compared, no significant difference between the two groups was observed (P> 022). In
addition, no interactions between dose and treatment were noted.
When the anti-peptidoglycan antibody levels of non-thymectomized rats were examined by
analysis of variance, no dose-effect on the amount of antibody produced was observed over this
limited range of cell wall concentration (P>0 71). In contrast, thymectomized rats showed a
logarithmic increase in maximum antibody concentration with increasing dose (P < 0-005). It was
also observed that interactions between dose and treatment (thymectomy or non-thymectomy)
were present (P<0 02). This means that there is a combined influence of the treatment (thymec-
tomy) and dose of cell wall on antibody response over and above the effects of each of these factors
considered separately.
Evaluation of the relationship between chronic joint lesion score and antibody concentration
The antibody and joint lesion data from thymectomized and non-thymectomized Sprague-Dawley
rats, injected with group A streptococcal cell wall fragments in doses of60 or 20 pg ofrhamnose per
g body weight, were examined by regression analysis. These groups were included in the analysis to
provide a broad range of antibody and joint lesion responses. It can be seen in Fig. 3 that no
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Fig. 3. Relationship between the maximum chronic joint score and the maximum concentration of anti-A
polysaccharide measured in ninety-one rats. (o) Non-thymectomized, (o) thymectomized. This regression
analysis includes thymectomized and non-thymectomized rats injected with cell wall fragments in a dose of60 or
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Fig. 4. Relationship between the maximum chronic joint score and the maximum concentration of anti-pepti-
doglycan. (o) Non-thymectomized, (o) thymectomized. (See legend to Fig. 3 for key.)
Table 1. Frequency distribution of chronic joint lesion score and anti-peptidoglycan concentration in serum
Anti-peptidoglycan (pg/ml)
Maximum
joint score 0-1 1-10 10-100
< 1 (negligible) 12* 2 0
1-5 (moderate) 13 5 0
> 5 (severe) 22 27 10
* Number of rats.
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relationship exists between the maximum antibody response to A polysaccharide and chronic joint
lesion scores (r=0 005). In a similar plot of the maximum antibody response to peptidoglycan
versus the maximum chronic joint lesion score (Fig. 4) the correlation coefficient was low (r= 0 17)
but significant (P<0 0001). Since this indicates a relationship between joint lesion score and
anti-peptidoglycan, a frequency distribution analysis of the data was performed (Table 1). All rats
(10/91) with a relatively high concentration of anti-peptidoglycan antibody ( > 10 jug/ml of serum)
developed severe chronic joint lesions. Amongst those rats with lower levels of antibody ( < 10 0
pg/ml) a greater proportion developed moderate or negligible joint lesions. However, it is equally
important to note that 46% (22/47) of the rats with very low antibody levels (0 to 1-0 jig/ml) also
developed severe chronic joint lesions.
DISCUSSION
Intraperitoneal injection of rats with cell wall fragments isolated from group A streptococci induces
an inflammation of the joints which reaches a peak in 3 to 5 days, depending upon the dose of cell
wall. This acute phase recedes over the next 10 days and is followed by development of a chronic
phase in which joint lesions recur in repeated cycles of remission and exacerbation over a period of6
months (Cromartie et al., 1977; Clark et al., 1979).
Two points relevant to the clinical course of the experimental disease emerge from the kinetic
study of antibody levels: (a) serum concentrations of both anti-A polysaccharide and anti-peptido-
glycan antibodies are decreasing at the time the chronic phase ofjoint inflammation is developing,
and the antibodies remain at background levels while the chronic remittent disease evolves; (b) the
antibody levels are decreasing 2 to 3 weeks after cell wall injection in spite of the persistence of cell
wall antigens within spleen, liver and joints for at least 180 days (Cromartie et al., 1977). Jones,
Amsbaugh & Prescott (1976) made similar observations in mice immunized with pneumococcal
polysaccharide, an antigen which is also slowly degraded and persists in tissue for prolonged
periods.
Both peptidoglycan and A polysaccharide would appear to be T-independent antigens since
thymectomy does not reduce the antibody response to these antigens. In fact, some of the
thymectomized rats exhibit higher antibody responses than non-thymectomized rats. The ability of
peptidoglycan to activate complement (Greenblatt, Boackle & Schwab, 1978) and act as a B cell
mitogen (Damais et al., 1975) are consistent with properties of T-independent antigens. Group A
polysaccharide, on the other hand, has been reported to be a T-dependent antigen in mice, at least
when injected as a component of whole streptococcal cells (Braun, Kindred & Jacobson, 1972).
Caution should be observed in defining these antigens as T-independent from the results presented
here. Thymectomized rats do not seem to be as severely immune depressed as other thymectomized
animals (Fisher & Fisher, 1965). The higher antibody response of some of the thymectomized rats
may only reflect the early seeding of peripheral lymphoid organs by helper T cells and selective
depletion of short-lived suppressor T cells (Kerbel & Eidinger, 1972). Furthermore, high doses of
antigen, such as those used in these studies, have been reported to elicit a normal response in
thymectomized animals (Bretscher, 1972).
A consistent feature of the immune response to group A polysaccharide and peptidoglycan is the
variation in the magnitude of the antibody response between animals. Rabbits, mice and rats
immunized intravenously with whole group A streptococci exhibit a similar variation. Even within
inbred strains, variations in antibody concentrations from 100- to 1,000-fold have been observed
(Eichmann, Braun & Krause, 1971; Braun et al., 1972; Leslie & Carwile, 1973). This wide variation
probably indicates that the antibody response to group A polysaccharide is under multigene control
(Eichmann et al., 1971; Briles, Krause & Davie, 1977). Similarly, anti-peptidoglycan antibody
concentrations have been reported to vary by more than 150-fold (Heymer et al., 1975b).
In a previous report an association between experimental joint disease and cell-mediated
immunity against cell wall antigens could not be detected (Hunter et al., 1980). The data presented
here show no correlation between disease and serum levels of antibody against the cell wall
polysaccharide. There is a trend toward association of higher serum levels of anti-peptidoglycan
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with more severe joint disease, but further studies are required to determine if this is a causal
relationship. Immune complexes, through the activation of complement and macrophages (Schor-
lemmer, Bitter-Suermann & Allison, 1977), can be a mechanism in the amplification of the
experimental disease and in maintaining its chronic course. However, the peptidoglycan-polysac-
charide cell wall structure can also activate the alternative complement pathway (Greenblatt et al.,
1978) and activate macrophages (Davies, Page & Allison, 1974; Smialowicz & Schwab, 1977)
without the requirement ofantibodies or lymphocytes. The essential component, common to either
mechanism, is the persistent bacterial cell wall which provides the prolonged presence of antigenic
and toxic peptidoglycan at the site of injury.
Studies on patients with rheumatoid arthritis also suggest a possible role for peptidoglycan and
antibody in the pathogenesis of human disease. When compared to normal subjects, patients with
rheumatoid arthritis have higher serum concentrations of anti-peptidoglycan antibodies (Scha-
chenmayr, Heymer & Hafer Kamp, 1975; Pope et al., 1979). Elevated levels of anti-peptidoglycan
antibodies have also been observed in patients with juvenile rheumatoid arthritis and acute
rheumatic fever (Heymer et al., 1976; Rolieka & Massel, 1973).
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